Vietnam Pharmaceuticals: key facts
Market size
How big is Vietnam's drug market?
Vietnam's drug market was about USD 8.0 bn in 2025, growing about 7% a year to 2030, according to KIRA's 2026 market report (Fortune BI 2025).
Source: Fortune BI 2025, 2025 · KIRA report: Vietnam pharma 2027 outlook: generics localization and biosimilar adoption
What share of hospital tender value goes to domestic suppliers in Vietnam?
Domestic suppliers held 26.2% of hospital tender value on a VND 34.7tn 2023 base, according to KIRA's 2026 market report (VSS 2024).
Source: VSS 2024, 2023 · KIRA report: Vietnam pharma 2027 outlook: generics localization and biosimilar adoption
Key players
How much of Imexpharm in Vietnam does SK Group own?
SK Group holds about 48% of Imexpharm, according to KIRA's 2026 market report (VIR 2024).
Source: VIR 2024, 2024 · KIRA report: Vietnam pharma 2027 outlook: generics localization and biosimilar adoption
Channels and distribution
What share of Vietnam's drug market is tender-driven ETC?
The tender-driven ETC channel accounts for about 75% of Vietnam's drug market value in 2025, according to KIRA's 2026 market report (Stellapharm 2025).
Source: Stellapharm 2025, 2025 · KIRA report: Vietnam pharma 2027 outlook: generics localization and biosimilar adoption
How much of Vietnam's drug market value does the pharmacy channel drive?
The pharmacy channel drives 61% of market value and grew 11% in H1 2025, according to KIRA's 2026 market report (VIRAC 2025).
Source: VIRAC 2025, 2025 · KIRA report: Vietnam pharma 2027 outlook: generics localization and biosimilar adoption
Pricing
How much cheaper are biosimilars than reference biologics in Vietnam?
Biosimilars trade at 50-70% ASP discounts to reference biologics, according to KIRA's 2026 market report (InsightAce 2025).
Source: InsightAce 2025 · KIRA report: Vietnam pharma 2027 outlook: generics localization and biosimilar adoption
Regulation
What is Decision 1165's domestic target for Vietnam's drug market?
Decision 1165 targets domestic drugs at 70% of market value by 2030, according to KIRA's 2026 market report (Decision 1165 2023).
Source: Decision 1165 2023, 2030 · KIRA report: Vietnam pharma 2027 outlook: generics localization and biosimilar adoption
How many plants in Vietnam hold EU-GMP certification?
Only 17 plants nationally hold EU-GMP certification, according to KIRA's 2026 market report (InvestVietnam 2025).
Source: InvestVietnam 2025 · KIRA report: Vietnam pharma 2027 outlook: generics localization and biosimilar adoption
Risks
How dependent is Vietnam on imported APIs?
Local production covers only a fraction of Vietnam's API needs, with import dependency above 80%, according to KIRA's 2026 market report (Kira estimates based on Davipharm + EuroCham 2024).
Source: Kira estimates based on Davipharm + EuroCham 2024, 2024 · KIRA report: Vietnam pharma 2027 outlook: generics localization and biosimilar adoption
Who's who
pharmaceutical products
47 companies in BizDirect Asia's database. Supplier list · Distributor list · Manufacturer list
- ЕУРО-ФАРМ
- Traphaco (Hung Yen)
- NVC PHARMA (Ho Chi Minh)
- Armephaco (Ha Noi)
- 横店集团控股有限公司
- Agimexpharm (An Giang)
- HDPHARMA (Hai Phong)
- CPC1 Hà Nội (Ha Noi)
- BIOPHARCO (Khanh Hoa)
- ATA Pharma (Ha Noi)
Top regions: Ha Noi (18), Ho Chi Minh (13), Dak Lak (1), An Giang (1), Bac Ninh (1)
active pharmaceutical ingredients
8 companies in BizDirect Asia's database. Distributor list · Manufacturer list
- Newchem S.p.A
- Nomura Trading Vietnam (Ho Chi Minh)
- Asia Shine (Ho Chi Minh)
- ACT Swiss (Ho Chi Minh)
- Deshangchemical-chemechemi
- Tradimed
- Egis Pharmaceuticals (Ho Chi Minh)
- CAN VN (Khanh Hoa)
Top regions: Ho Chi Minh (4), Khanh Hoa (1)
pharmaceutical excipients
10 companies in BizDirect Asia's database. Distributor list
- Cargill
- GoldenSand (Ho Chi Minh)
- Vĩnh Nam Anh
- CÔNG TY CP XNK DƯỢC MẶT TRỜI
- Smart Ingredients (Ho Chi Minh)
- Asia Shine (Ho Chi Minh)
- Glandcore (Ho Chi Minh)
- F.D&C (Phu Tho)
- VPHARCHEM - HOÁ DƯỢC VIỆT (Ho Chi Minh)
- CAN VN (Khanh Hoa)
Top regions: Ho Chi Minh (5), Phu Tho (1), Khanh Hoa (1)
pharmaceutical raw materials
20 companies in BizDirect Asia's database. Supplier list · Distributor list · Manufacturer list · Wholesaler list
- HÓA DƯỢC - DƯỢC PHẨM I (Ha Noi)
- Dược Hà Tây (Ha Noi)
- Yteco (Ho Chi Minh)
- Sapharco (Ho Chi Minh)
- Masenz - Pharma International
- Traphaco CNC (Hung Yen)
- Mapbiopharma
- Biozym (Ho Chi Minh)
- Kanetora (Hai Phong)
- Hai Dang (Ha Noi)
Top regions: Ho Chi Minh (8), Ha Noi (7), Phu Tho (1), Hung Yen (1), Hai Phong (1)
Company data: BizDirect Asia (sister company)